Product
Oral Solifenacin
1 clinical trial
2 indications
Indication
Overactive BladderIndication
Overactive Bladder SyndromeClinical trial
A Prospective Randomized Controlled Trial: Comparison of the Transcutaneous Posterior Tibial Nerve Stimulation and Oral Solifenacin Treatments' Effects in Women Between 18-80 Years Old Who Have Overactive BladderStatus: Completed, Estimated PCD: 2023-05-24